ConductScience.org, home

Paper40508147

Phage-Antibiotic Synergy Enhances Biofilm Eradication and Survival in a Zebrafish Model of Pseudomonas aeruginosa Infection.

Lin LC and 2 others. Int J Mol Sci, 2025. Cited by 16 papers, by iCite.

Cite this record

ConductScience Library. Phage-Antibiotic Synergy Enhances Biofilm Eradication and Survival in a Zebrafish Model of Pseudomonas aeruginosa Infection. Papers, record 40508147. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40508147

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Phage-Antibiotic Synergy Enhances Biofilm Eradication and Survival in a Zebrafish Model of Pseudomonas aeruginosa Infection.
PubMed
Journal
Int J Mol Sci
PubMed
Year
2025
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
16
iCite
Relative citation ratio, by iCite
5.4, provisional
iCite
Revised in PubMed
2025-06-15
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Lin LCLing-Chun
2Tsai YCYu-Chuan
3Lin NTNien-Tsung

Source PubMed

Download CSV of authors

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
BiofilmsMajor topic
Pseudomonas aeruginosaMajor topic
Pseudomonas InfectionsMajor topic
Anti-Bacterial AgentsMajor topic
Pseudomonas PhagesMajor topic
Animals
Zebrafish
Disease Models, Animal
Drug Synergism
Imipenem
Microbial Sensitivity Tests

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
TCMRC-P-111005Tzu Chi UniversityPubMed

Source PubMed

Download CSV of grants

References60

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
139717533The Bacterial Biofilms: Formation, Impacts, and Possible Management Targets in the Healthcare System.Can J Infect Dis Med Microbiol2024https://conductscience.org/library/papers/39717533PubMed
231359029Predicting promoters in phage genomes using PhagePromoter.Bioinformatics2019https://conductscience.org/library/papers/31359029PubMed
337490958Therapeutic effect and anti-biofilm ability assessment of a novel phage, phiPA1-3, against carbapenem-resistant Pseudomonas aeruginosa.Virus Res2023https://conductscience.org/library/papers/37490958PubMed
429018773Activity of Bacteriophages in Removing Biofilms of Pseudomonas aeruginosa Isolates from Chronic Rhinosinusitis Patients.Front Cell Infect Microbiol2017https://conductscience.org/library/papers/29018773PubMed
539483571Biofilm Formation in Chronic Infections: A Comprehensive Review of Pathogenesis, Clinical Implications, and Novel Therapeutic Approaches.Cureus2024https://conductscience.org/library/papers/39483571PubMed
61457665Epidemiology of infections with Pseudomonas aeruginosa in burn patients: the role of hydrotherapy.Clin Infect Dis1992https://conductscience.org/library/papers/1457665PubMed
735072601ResFinder - an open online resource for identification of antimicrobial resistance genes in next-generation sequencing data and prediction of phenotypes from genotypes.Microb Genom2022https://conductscience.org/library/papers/35072601PubMed
838858621Quorum sensing gene lasR promotes phage vB_Pae_PLY infection in Pseudomonas aeruginosa.BMC Microbiol2024https://conductscience.org/library/papers/38858621PubMed
935354477Bacteriophages and antibiotic interactions in clinical practice: what we have learned so far.J Biomed Sci2022https://conductscience.org/library/papers/35354477PubMed
1035034585Antibiotic resistance in hospital-acquired ESKAPE-E infections in low- and lower-middle-income countries: a systematic review and meta-analysis.Emerg Microbes Infect2022https://conductscience.org/library/papers/35034585PubMed
1111577145Prevalence of type III secretion genes in clinical and environmental isolates of Pseudomonas aeruginosa.Microbiology (Reading)2001https://conductscience.org/library/papers/11577145PubMed
1237141106Virus taxonomy and the role of the International Committee on Taxonomy of Viruses (ICTV).J Gen Virol2023https://conductscience.org/library/papers/37141106PubMed
1321110836Characterization of JG024, a pseudomonas aeruginosa PB1-like broad host range phage under simulated infection conditions.BMC Microbiol2010https://conductscience.org/library/papers/21110836PubMed
1432753497Phage-Antibiotic Synergy Is Driven by a Unique Combination of Antibacterial Mechanism of Action and Stoichiometry.mBio2020https://conductscience.org/library/papers/32753497PubMed
1526629485The Frequency of Exotoxin A and Exoenzymes S and U Genes Among Clinical Isolates of Pseudomonas aeruginosa in Shiraz, Iran.Int J Mol Cell Med2015https://conductscience.org/library/papers/26629485PubMed
1624600439The factors affecting effectiveness of treatment in phages therapy.Front Microbiol2014https://conductscience.org/library/papers/24600439PubMed
1736998407Characterization of a lytic Pseudomonas aeruginosa phage vB_PaeP_ASP23 and functional analysis of its lysin LysASP and holin HolASP.Front Microbiol2023https://conductscience.org/library/papers/36998407PubMed
1833668899Synergistic Killing and Re-Sensitization of Pseudomonas aeruginosa to Antibiotics by Phage-Antibiotic Combination Treatment.Pharmaceuticals (Basel)2021https://conductscience.org/library/papers/33668899PubMed
1938903659High prevalence of multidrug-resistant Pseudomonas aeruginosa carrying integron and exoA, exoS, and exoU genes isolated from burn patients in Ahvaz, southwest Iran: A retrospective study.Health Sci Rep2024https://conductscience.org/library/papers/38903659PubMed
2028828194Phage therapy: An alternative to antibiotics in the age of multi-drug resistance.World J Gastrointest Pharmacol Ther2017https://conductscience.org/library/papers/28828194PubMed

See all 60 referencesDownload CSV of references

Cited by15

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 16 citations.

PMIDTitleJournalYearIn PapersSource
42943529From Antagonism to Coevolutionary Regulation: Multidimensional Phage-Biofilm Interaction Networks and Translational Targeted Anti-Infection Strategies.Microorganisms2026https://conductscience.org/library/papers/42943529PubMed
42746437Precision bacteriophage therapy for multidrug-resistant recurrent urinary tract infections: From biological rationale to clinical translation in Taiwan.Tzu Chi Med J2026https://conductscience.org/library/papers/42746437PubMed
42687318Genomic and Phenotypic Characterization of Two Novel Enterobacter Phages With EDTA-Enhanced Antibiofilm Activity.Microbiologyopen2026https://conductscience.org/library/papers/42687318PubMed
42611076Bacteriophage therapy for antimicrobial-resistant, biofilm‑associated diabetic foot infection: delivery routes, phage antibiotic synergy, and practical wound‑care integration.Arch Microbiol2026https://conductscience.org/library/papers/42611076PubMed
42164670Phage enabled precision drug delivery: dual function platforms for therapeutics and genetic cargo transport.Front Microbiol2026https://conductscience.org/library/papers/42164670PubMed
42113464Integrating resistance biology, virulence networks, and precision therapeutics against multidrug-resistant Pseudomonas aeruginosa.Infection2026https://conductscience.org/library/papers/42113464PubMed
42100706Characterization and phage-antibiotic synergy of bacteriophages PES-1 and PES-2 against porcine enterotoxigenic Escherichia coli.Front Microbiol2026https://conductscience.org/library/papers/42100706PubMed
42074308Phage Therapy in Gastrointestinal Diseases: Current Status and Challenges.Int J Mol Sci2026https://conductscience.org/library/papers/42074308PubMed
41922975Synergistic disinfection by phage PLY101 and 1.3-dibromo-5.5-dimethylhydantoin (DBDMH) against resistant Proteus mirabilis.BMC Microbiol2026https://conductscience.org/library/papers/41922975PubMed
41879899Characterization, genomic insights and anti-biofilm potential of phage vB_PaeM_PKMS3, a lytic Pbunavirus capable of infecting clinical Pseudomonas aeruginosa isolates.Antonie Van Leeuwenhoek2026https://conductscience.org/library/papers/41879899PubMed
41597628Understanding Pseudomonas aeruginosa Biofilms: Quorum Sensing, c-di-GMP Signaling, and Emerging Antibiofilm Approaches.Microorganisms2026https://conductscience.org/library/papers/41597628PubMed
41247565Advances in combating antimicrobial resistance in MRSA: a comprehensive review on nanotechnology and phage therapy.Antonie Van Leeuwenhoek2025https://conductscience.org/library/papers/41247565PubMed
41229989Efficacy of Phage Cocktails Against Biofilms Formed by Antibiotic-Resistant Bacteria.Infect Drug Resist2025https://conductscience.org/library/papers/41229989PubMed
41156622Phage to ESKAPE: Personalizing Therapy for MDR Infections-A Comprehensive Clinical Review.Pathogens2025https://conductscience.org/library/papers/41156622PubMed
40943617Bacteriophage-Based Approach Against Biofilm Infections Associated with Medical Devices: A Narrative Review of ESKAPE Pathogens.Int J Mol Sci2025https://conductscience.org/library/papers/40943617PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/40508147

GET https://conductscience.org/api/papers/v1/40508147/references?page=2